Managed entry
Revision as of 12:30, 9 November 2023 by Editor iHTS (talk | contribs) (Created page with "''<small><sup>23</sup>Klemp M, Frønsdal KB, Facey K. What principles should govern the use of managed entry agreements? Int J Technol Assess Health Care. 2011 Jan;27(1):77-83.</small>'' A conditional arrangement between manufacturer and payer that enables earlier reimbursement of a health technology to address uncertainty in its performance or to manage its utilization. '''Note 1:''' Related terms include managed entry agreement, managed entry scheme, coverage with e...")
23Klemp M, Frønsdal KB, Facey K. What principles should govern the use of managed entry agreements? Int J Technol Assess Health Care. 2011 Jan;27(1):77-83.
A conditional arrangement between manufacturer and payer that enables earlier reimbursement of a health technology to address uncertainty in its performance or to manage its utilization.
Note 1: Related terms include managed entry agreement, managed entry scheme, coverage with evidence development, and managed access.